News & Updates

Show Multimedia Only

Socioeconomic status tied to low use of adjuvant immunotherapy in stage III melanoma

17 Nov 2024

Patients with stage III melanoma show inconsistent use of adjuvant immunotherapy despite its survival benefits, according to a study.

Socioeconomic status tied to low use of adjuvant immunotherapy in stage III melanoma

17 Nov 2024

Dual JAK3/TEC inhibition may induce hair regrowth in alopecia areata

12 Nov 2024

Dual JAK3/TEC inhibition may induce hair regrowth in alopecia areata (AA), an autoimmune disorder characterized by nonscarring hair loss.

Dual JAK3/TEC inhibition may induce hair regrowth in alopecia areata

12 Nov 2024

Data support abrocitinib use beyond 2 years in adolescents with AD

05 Nov 2024 by

Treating adolescents with moderate-to-severe AD with the JAK1-selective inhibitor abrocitinib has demonstrated an acceptable long-term safety profile and maintained efficacy for up to 112 weeks, as shown in an adolescent-focused post hoc analysis of 5 phase III trials

Data support abrocitinib use beyond 2 years in adolescents with AD

05 Nov 2024

Childhood eczema takes a toll on children’s and parents’ mental health

04 Nov 2024 by

Eczema severity in children is associated with depression, anxiety and stress in both children with eczema and their parents, a cross-sectional study in Hong Kong has shown.

Childhood eczema takes a toll on children’s and parents’ mental health

04 Nov 2024

Pregabalin relieves pain, itch in recessive dystrophic epidermolysis bullosa

03 Nov 2024

In patients with recessive dystrophic epidermolysis bullosa, treatment with pregabalin appears to substantially reduce pain and itch, according to a randomized crossover trial.

Pregabalin relieves pain, itch in recessive dystrophic epidermolysis bullosa

03 Nov 2024

Continued awareness expedites diagnosis in calciphylaxis

01 Nov 2024

In patients with calciphylaxis, diagnostic delay and complications have dropped over time, according to a study. In addition, the number of deaths has decreased in recent years. These findings stress the importance of awareness to speed up diagnosis.

Continued awareness expedites diagnosis in calciphylaxis

01 Nov 2024

Tumour size, age predict survival in dermatofibrosarcoma protuberans

31 Oct 2024

The incidence of dermatofibrosarcoma protuberans (DFSP) is two times higher among Black than White individuals, reports a study.

Tumour size, age predict survival in dermatofibrosarcoma protuberans

31 Oct 2024

Hidradenitis suppurativa raises maternal, offspring risks

23 Oct 2024

Hidradenitis suppurativa (HS) poses increased risk of adverse maternal and offspring outcomes not only during the peripartum period but also in the long term, according to a study.

Hidradenitis suppurativa raises maternal, offspring risks

23 Oct 2024

Subgroup analysis bolsters trifarotene role in acne scar management

23 Oct 2024 by

A post hoc analysis of a phase IV study presented at EADV 2024 underscores the ability of the fourth-generation retinoid trifarotene to reduce atrophic acne scars across all skin types, with a more profound effect among individuals with higher baseline acne and acne scarring severity.

Subgroup analysis bolsters trifarotene role in acne scar management

23 Oct 2024

$Prior nonmelanoma skin cancer tied to fewer fractures in old age$

Prior nonmelanoma skin cancer tied to fewer fractures in old age

22 Oct 2024

Older adults with a history of nonmelanoma skin cancer (NMSC) appear to have fewer incident fractures, according to a study.

Prior nonmelanoma skin cancer tied to fewer fractures in old age

22 Oct 2024

News & Updates

Filter by Specialty:

Specialty:

Socioeconomic status tied to low use of adjuvant immunotherapy in stage III melanoma

Socioeconomic status tied to low use of adjuvant immunotherapy in stage III melanoma

Dual JAK3/TEC inhibition may induce hair regrowth in alopecia areata

Dual JAK3/TEC inhibition may induce hair regrowth in alopecia areata

Data support abrocitinib use beyond 2 years in adolescents with AD

Data support abrocitinib use beyond 2 years in adolescents with AD

Childhood eczema takes a toll on children’s and parents’ mental health

Childhood eczema takes a toll on children’s and parents’ mental health

Pregabalin relieves pain, itch in recessive dystrophic epidermolysis bullosa

Pregabalin relieves pain, itch in recessive dystrophic epidermolysis bullosa

Continued awareness expedites diagnosis in calciphylaxis

Continued awareness expedites diagnosis in calciphylaxis

Tumour size, age predict survival in dermatofibrosarcoma protuberans

Tumour size, age predict survival in dermatofibrosarcoma protuberans

Hidradenitis suppurativa raises maternal, offspring risks

Hidradenitis suppurativa raises maternal, offspring risks

Subgroup analysis bolsters trifarotene role in acne scar management

Subgroup analysis bolsters trifarotene role in acne scar management

Prior nonmelanoma skin cancer tied to fewer fractures in old age

Prior nonmelanoma skin cancer tied to fewer fractures in old age